Study highlights physician perspectives on emerging anti-amyloid treatments for Alzheimer's disease
In a recent study, Tel Aviv Sourasky Medical Center has shed light on physician attitudes toward novel anti-amyloid ...
WebMD24m
First-in-Class Leukemia Treatment Approved by FDA
The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.